Today: 22 March 2026
Subscribe
Browse Category

Stock Market 12 January 2026

Nextpower (NXT) stock jumps on Saudi joint venture launch and 12‑GW factory plan

Nextpower (NXT) stock jumps on Saudi joint venture launch and 12‑GW factory plan

Nextpower shares rose about 9% Monday after the company confirmed its Saudi joint venture and detailed plans for a Jeddah manufacturing facility targeting 12 GW annual solar tracker capacity by Q2 2026. The stock reached $99.70 before settling at $99.62. Partners plan to invest $88 million over two years. Traders await updates on orders and spending at the Jan. 27 earnings call.
12 January 2026
··
Lockheed Martin stock today: LMT edges up as defense names catch a safety bid

Lockheed Martin stock today: LMT edges up as defense names catch a safety bid

Lockheed Martin shares rose $2.70 to $545.62 Monday as investors moved into defense stocks ahead of Tuesday’s CPI report and amid market volatility. Gains followed threats from the Trump administration to indict Fed Chair Jerome Powell and a proposal to cap credit card interest rates, which pressured financial stocks. Gold and defense shares rallied after Trump floated seizing Greenland. Lockheed reports Q4 earnings Jan. 29.
12 January 2026
···
AbbVie stock slips after $650 million RemeGen cancer-drug deal and Arizona plant buy

AbbVie stock slips after $650 million RemeGen cancer-drug deal and Arizona plant buy

AbbVie shares fell 0.6% to $218.81 after announcing a $650 million licensing deal with China’s RemeGen for the experimental cancer drug RC148. RemeGen could receive up to $4.95 billion in milestones and royalties. AbbVie also agreed to buy a device manufacturing plant in Tempe, Arizona, from West Pharmaceutical Services. The S&P health-care sector declined while the broader market rose.
12 January 2026
···
ServiceNow stock steadies after Goldman’s fresh “Buy” call as earnings near

ServiceNow stock steadies after Goldman’s fresh “Buy” call as earnings near

Goldman Sachs initiated coverage of ServiceNow with a Buy rating and a $205 price target Monday, sending shares up 0.2% to around $142 in afternoon trading. The move follows a 3% drop last week. Investors are focused on ServiceNow’s Jan. 28 earnings report for signals on 2026 growth and demand. Stifel recently cut its price target to $200, citing concerns over federal contract trends.
12 January 2026
···
Visa stock slides as Trump’s 10% credit-card rate cap talk hits payments names

Visa stock slides as Trump’s 10% credit-card rate cap talk hits payments names

Visa shares fell 1.6% to $344.25 by early afternoon Monday after President Trump proposed a one-year 10% cap on credit-card interest rates. Mastercard dropped 1.8%, American Express 4.2%. Analysts said such a cap would require Congressional approval, but the announcement increased volatility in card-related stocks. Traders are watching upcoming bank earnings and Tuesday’s CPI for further signals on consumer credit.
12 January 2026
···
IREN stock jumps nearly 9% today as Bernstein tags Nasdaq’s IREN a ‘top AI pick’

IREN stock jumps nearly 9% today as Bernstein tags Nasdaq’s IREN a ‘top AI pick’

IREN Limited shares surged 9% to $50.05 by midday Monday, outpacing other U.S.-listed bitcoin miners. The rally followed Bernstein analyst Gautam Chhugani naming IREN his “top AI pick” and setting a $150,000 bitcoin target for 2026. About 29.2 million shares traded after Friday’s close. Investors are watching Tuesday’s U.S. inflation data for further market direction.
12 January 2026
·
EOSE stock jumps nearly 10%: what to watch in Eos Energy Enterprises before the Jan. 14 webcast

EOSE stock jumps nearly 10%: what to watch in Eos Energy Enterprises before the Jan. 14 webcast

Eos Energy Enterprises shares jumped nearly 10% to $16.76 by midday Monday, with trading volume approaching 19.6 million shares. Short interest stood at 82.8 million shares, or 29.7% of float, as of Dec. 15. Investors await the company’s webcast on Jan. 14 for updates on manufacturing and funding. Eos recently raised $600 million via convertible notes and $458 million in a direct stock sale.
12 January 2026
··
Nvidia stock gains on Eli Lilly $1 billion AI lab plan as traders eye TSMC, earnings

Nvidia stock gains on Eli Lilly $1 billion AI lab plan as traders eye TSMC, earnings

Nvidia and Eli Lilly will invest up to $1 billion in a Bay Area AI drug discovery lab over five years, sending Nvidia shares up 0.8% to $186.37 and Lilly up 0.2% to $1,066.14. AMD, Broadcom, and TSMC also rose as AI-focused stocks lifted the Nasdaq. TSMC reports earnings Jan. 15, with analysts expecting a 27% Q4 profit jump on AI chip demand. Nvidia’s next earnings are due Feb. 25.
12 January 2026
···
Bitcoin price edges higher near $91,000 as Strategy buys $1.25B of BTC; Coinbase stock climbs

Bitcoin price edges higher near $91,000 as Strategy buys $1.25B of BTC; Coinbase stock climbs

Bitcoin rose 0.3% to $91,147 Monday as Coinbase and Marathon Digital shares also gained. Fed Chair Jerome Powell confirmed the Justice Department served the central bank with grand jury subpoenas, sending the dollar lower and gold to a record above $4,600 an ounce. Strategy bought 13,627 bitcoin last week, bringing its holdings to 687,410. Traders await Tuesday’s U.S. CPI report and the Fed’s Jan. 27-28 meeting.
12 January 2026
······
1 … 531 532 533 534 535 … 1,358

Stock Market Today

  • Pro Medicus (ASX:PME) Valuation Faces Mixed Signals After Leadership Changes
    March 22, 2026, 12:50 AM EDT. Pro Medicus (ASX:PME) has restructured its senior leadership, appointing Danny English as CFO and moving Clayton Hatch to combined operational roles. The stock trades at A$120.06, down 2.09% in one day and 46.07% year-to-date, despite a strong 5-year total return of 173.62%. Analysts suggest the company is 39% undervalued with a fair value at A$196.78, citing steady revenue growth and expanding market potential. However, its high price-to-earnings (P/E) ratio of 53.4x exceeds peers and fair estimates, posing a valuation risk if growth expectations are not met. Key risks include accelerated AI adoption in imaging and contract delays with U.S. hospitals. Investors face a split market sentiment on PME's true value amid recent leadership changes and performance concerns.
Go toTop